Oxford Drug Design

@OxDrugDes

A drug-discovery company focusing on anti-infectives

Vrijeme pridruživanja: siječanj 2017.

Tweetovi

Blokirali ste korisnika/cu @OxDrugDes

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @OxDrugDes

  1. prije 2 sata
    Poništi
  2. 4. velj

    A previously unknown mechanism enables bacterial antibiotic resistance

    Poništi
  3. 30. sij
    Poništi
  4. 24. sij

    Watch our resident mathematician explain how to spot a "deepfake" video

    Poništi
  5. 24. sij

    Interesting article "Joining the computer-aided battle against antibiotic resistance" by in - featuring us!

    Poništi
  6. 24. sij
    Poništi
  7. 23. sij
    Poništi
  8. 21. sij

    WHO reports lack of investment and innovation in the fight against resistant particularly those targeting Gram-negative species ODD is developing novel compounds with activity against these dangerous organisms

    Poništi
  9. 17. sij
    Poništi
  10. 14. sij

    ODD down the pub again, celebrating one of us getting even older last week. Plus, welcome to Tracy who's just joined us.

    Poništi
  11. 13. sij
    Poništi
  12. 13. sij

    There's an upcoming webinar on "Testing for the potential of emergence of antimicrobial resistance" with Michael Mourez 16.00 GMT on Tues 21st Jan

    Poništi
  13. proslijedio/la je Tweet
    8. sij

    NEWS NEWS -- is funding TAXIS Pharmaceuticals to develop efflux pump inhibitor to disarm superbugs' ability to resist antibiotics

    Poništi
  14. 9. sij
    Poništi
  15. 6. sij

    An analysis of the issues at Melinta by A mismatch of the cost of delivering new and what the market will pay

    Poništi
  16. 2. sij

    Another antibiotic developer in trouble : Melinta initiates voluntary bankruptcy proceedings

    Poništi
  17. proslijedio/la je Tweet
    12. pro 2019.

    Scientists at IU can now watch bacteria acquire new antibiotic resistance genes by 'natural transformation' in real time. Details: . Published in Cell:

    Poništi
  18. 17. pro 2019.

    Merck’s last-resort Recarbrio nears EU approval via

    Poništi
  19. 16. pro 2019.

    What are new really worth? - ​ via

    Poništi
  20. 10. pro 2019.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·